How CMS in­de­pen­dence is at the fore­front of its Alzheimer's drug cov­er­age de­ci­sion

4 years ago
Pharma
FDA+

Car­lyle vaults in­to biotech in­vest­ing, buy­ing Abing­worth and launch­ing a new com­pa­ny aimed at piv­otal leaps

4 years ago
Deals

Ex­clu­sive: Flag­ship snags an­oth­er CEO-part­ner, on a per­son­al mis­sion, to lead its tR­NA boat

4 years ago
People
Startups

AACR22: As post-Covid de­vel­op­ment takes shape, BioN­Tech re­ports first hu­man da­ta for CAR-T/can­cer vac­cine com­bo

4 years ago
R&D
Cell/Gene Tx

AACR22: Am­gen re­veals new long-term da­ta for Lumakras, look­ing to keep press­ing mar­ket ad­van­tage over Mi­rati

4 years ago
R&D
Pharma

AACR22: Af­fimed's NK cell ther­a­py pro­duces more pa­tient re­spons­es — and more dura­bil­i­ty ques­tions

4 years ago
R&D
Cell/Gene Tx

Biotechs take a beat­ing in first round of #AACR22 as weak da­ta crip­ple share prices

4 years ago
R&D

Ear­ly win­ner emerges at #AACR22 as a transat­lantic hy­brid posts an up­beat snap­shot for urothe­lial can­cer

4 years ago
R&D

Lat­est news on ‘dev­as­tat­ing’ Ab­b­Vie drug dis­con­tin­u­a­tion; Bio­gen's worst case sce­nario; Fi­nal­ly, some M&A; and ...

4 years ago
Weekly

Scoop: Ab­b­Vie drops IBS drug Viberzi in Cana­da, 'dev­as­tat­ing' pa­tients

4 years ago
Pharma

An­oth­er lot of Mod­er­na's Rovi-made Spike­vax re­called af­ter par­tic­u­late found in vial

4 years ago
Pharma
Coronavirus

WP­P's VM­LY&R Health taps vet­er­an Gillis for CEO, amid re­fresh and first-ever health­care C-suite

4 years ago
Pharma
Marketing

Lon­za­'s au­toma­tive man­u­fac­tur­ing tech ac­quired by Mil­li­pore­Sig­ma

4 years ago
Pharma
Manufacturing

Rid­ing on coat­tails of Comir­naty suc­cess, BioN­Tech wins mR­NA man­u­fac­tur­ing con­tract with Ger­man gov­ern­ment

4 years ago
R&D
Manufacturing

AACR22: Ru­bius touts new da­ta for lead pro­gram, but shares rout­ed as in­vestors flee

4 years ago
R&D

What did we learn from Bio­gen's CMS slap­down? Da­ta rule

4 years ago
Bioregnum

Vi­a­tris dou­bles down on Sesame Work­shop col­lab­o­ra­tion, kick­ing in an­oth­er $1M

4 years ago
Pharma

As part of scheme to triple rev­enue this year, AGC adds on to Spain site for HPA­PIs

4 years ago
Pharma
Manufacturing

As­traZeneca ad­vances net-ze­ro car­bon goals, adding Hon­ey­well deal and out­sider over­sight among new ESG ef­forts

4 years ago
Pharma
Marketing

Flag­ship-backed mi­cro­bio­me com­pa­ny Kalei­do Bio­sciences shuts down

4 years ago
People
Startups

Phar­ma vets with Genen­tech con­nec­tion band to­geth­er to launch new im­munother­a­py start­up, though de­tails are scant

4 years ago
Financing
Startups

Fac­ing emp­ty re­serves by year's end, Lyra is rais­ing near­ly dou­ble its 2020 IPO as it en­ters PhI­II

4 years ago
Financing
Startups

BioCryst halts en­roll­ment in all stud­ies for its lead pipeline can­di­date — shares crash

4 years ago
R&D

De­layed at the EMA, a gene ther­a­py play­er is grap­pling with a cash crunch

4 years ago
Pharma
Cell/Gene Tx
First page Previous page 542543544545546547548 Next page Last page
A service from the Financial Times